Real-world practice adoption of latest guidelines for the acute management of ACS patients
Sponsored by Chiesi Farmaceutici
Coronary Interventions
Other coronary interventions
Pharmacology
Case in Point
Drugs and Devices Synergy
Room 243
Anchorperson: Jolanta Siller-Matula
Spokesperson: Dominick Angiolillo
Discussants: Leonardo De Luca, Jennifer Rymer, Troels Thim, Uwe Zeymer
Watch this session if you want
- To learn about latest guidelines recommendations on peri-PCI antithrombotic therapy for ACS patients
- To learn about recent new data on acute antithrombotic management of ACS patients from the real-world European and American scenario
- To discuss related real-world clinical cases of cangrelor use
Session objectives
Jolanta Siller-Matula
Guidelines recommendations on antiplatelet therapy for ACS patients: latest updates on acute management
Dominick Angiolillo
Contemporary peri-PCI antithrombotic management in Italy: insights from the EYESHOT 2 registry
Leonardo De Luca
Clinical case: urgent PCI on STEMI patient
Troels Thim
Discussion and audience interaction
Case conclusion
Troels Thim
Clinical case: PCI on high-risk NSTE-ACS patient
Jennifer Rymer
Discussion and audience interaction
Case conclusion
Jennifer Rymer
Clinical case: PCI after cardio-pulmonary resuscitation and cardiogenic shock
Uwe Zeymer
Discussion and audience interaction
Case conclusion
Uwe Zeymer
Session evaluation and key learnings
Dominick Angiolillo
